Navigation Links
Natalie Cole Lauds DaVita and CEO Kent Thiry on 'Larry King Live'
Date:4/1/2009

Legendary Singer Discusses Life on Dialysis and Her 'Wonderful' Experience at DaVita Facility

EL SEGUNDO, Calif., April 1 /PRNewswire-FirstCall/ -- Grammy-winning singer and songwriter Natalie Cole appeared last night on CNN's "Larry King Live" and discussed her battle with kidney failure and her "wonderful" experience receiving dialysis treatments at a dialysis facility owned and operated by DaVita Inc. (NYSE: DVA), a leading provider of kidney care services for those diagnosed with chronic kidney disease (CKD).

(Logo: http://www.newscom.com/cgi-bin/prnh/20020729/DAVITALOGO)

"There's a wonderful facility that I go to called DaVita. There's a gentleman named Kent Thiry who founded this organization some - a little a little while ago," said Cole in her discussion with King. "I've just met him very recently. There's now 1,400 of these [DaVita] facilities around the country...I mean there are so many people that are in some form of -- are having some form of dialysis around the country. It's amazing. It's like almost half a million people now."

Cole has been undergoing regular dialysis treatments three times per week, enabling her to continue her career and even go on tour to promote her newest album, Still Unforgettable. From the transcript of her appearance on "Larry King Live," she said: "I have a wonderful team of people at my facility here in Los Angeles that I tell them where I'm going and they make phone calls and make appointments. And it's really quite amazing. I have been on dialysis in Istanbul, Milan, Indonesia, Manila, London. It's -- it's amazing. It's really fascinating."

Chronic kidney disease is a silent epidemic affecting 26 million adult Americans - 90 percent of whom do not know they are at risk. DaVita(R) provides life-saving treatments to 1 in 4 Americans undergoing dialysis, a process for patients with kidneys that are no longer able to clean toxins and waste product from their blood.

DaVita is a registered trademark of DaVita Inc. All trademarks are the property of their respective owners.

About DaVita Inc.

DaVita Inc., a FORTUNE 500(R) company, is a leading provider of kidney care in the United States, providing dialysis services and education for patients with chronic kidney failure and end stage renal disease. DaVita manages more than 1,400 outpatient facilities and acute units in more than 700 hospitals located in 43 states and the District of Columbia, serving approximately 110,000 patients. As part of DaVita's commitment to building a healthy, caring community, DaVita develops, participates in and donates to numerous programs dedicated to transforming communities and creating positive, sustainable change for children, families and our environment. For more information about DaVita, its kidney education materials, and its community programs, please visit www.davita.com.


'/>"/>
SOURCE DaVita Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Natural Nutritions Spokesperson and Athlete Natalie Waples Wins 2008 Arnold Amateur Figure Championship
2. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
3. AAOMS Applauds Legislation Enabling Medicare Patients to Rehabilitate and Recover More Efficiently From Oral and Maxillofacial Injuries
4. Cord Blood America Applauds Congressional Effort Supporting Cord Blood Storage
5. Americans United for Life Applauds Ruling Directing Missouri to Issue Choose Life Plate
6. Coalition to Protect Senior Care Applauds Senate Finance Health Subcommittee Hearing on Long Term Care Improvement as Part of Broad Health Care Reform
7. Susan G. Komen for the Cure(R) Advocacy Alliance Applauds Senators Kennedy, Hutchison for Bipartisan Cancer Alert Act
8. Council for American Medical Innovation Applauds President Obama for Calling for Serious Investments in Science and Technology
9. Christopher & Dana Reeve Foundation Applauds Historic Passage of the Christopher and Dana Reeve Paralysis Act
10. Advocates for Youth Applauds Court Ruling on EC Age Restriction
11. eHealth Initiative Applauds Appointment of David Blumenthal as New National Coordinator for Health Information Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... The Patient Advocacy Community of The Beryl ... 2017 Ruth Ravich Patient Advocacy Award in recognition of her extraordinary contributions ... with the award at The Beryl Institute’s annual Patient Experience Conference on ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... Alive ... people who wish to overcome their mental health struggles. The Alive team uses ... LeBouthillier says: “Our approach in dealing with a mental health struggle is based on ...
(Date:4/21/2017)... Ramon, CA (PRWEB) , ... April 21, 2017 , ... ... might not understand the estate planning process, or where to even begin. “Now more ... unresolved if you are to properly protect yourself and your family,” said attorney Lisa ...
(Date:4/21/2017)... ... April 21, 2017 , ... During April 21-23, Super-Sod will join the ... festival offers entertainment for everyone — from the avid gardener to the landscape admirer ... high quality event held in a grand venue, and we are certainly looking forward ...
(Date:4/21/2017)... ... April 21, 2017 , ... MiracleFeet announced today ... years to help end the disability caused by untreated clubfoot in low-income countries. ... Global Clubfoot Initiative to end disability caused by clubfoot worldwide. , ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... BOSTON , April 20, 2017   ZappRx, Inc ... the specialty drug prescribing process, today announced it closed $25 ... Fund, a venture capital firm based in Seattle ... Qiming Venture Partners . The Series B round included ... A round in 2014, and GV (formerly Google ...
(Date:4/20/2017)... 20, 2017 NeuroVive Pharmaceutical AB (Nasdaq ... positive preclinical results demonstrating anti-fibrotic effects with ... steatohepatitis (NASH), in an additional well-validated experimental ... has previously shown similar anti-fibrotic effects in ... scientists present novel data demonstrating anti-fibrotic effects ...
(Date:4/19/2017)... 2017 The Mobile X-Ray product segment is the ... during the forecast period Mobile X-Ray segment is ... mobile X-Ray devices market, which is estimated to be valued ... a CAGR of 7% over the forecast period. Mobile X-Ray ... than US$ 100 Mn in 2017 over 2016. The segment,s ...
Breaking Medicine Technology: